In Re GOPALAN
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit
IN RE: SURESH GOPALAN, Appellant
2019-2070
Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. 13/926,096.
Decided: April 13, 2020
SURESH GOPALAN, Cambridge, MA, pro se.
MOLLY R. SILFEN, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA, for appellee Andrei Iancu. Also represented by THOMAS W. KRAUSE, AMY J. NELSON, FARHEENA YASMEEN RASHEED.
Before MOORE, CLEVENGER, and CHEN, Circuit Judges. CHEN, Circuit Judge.
Suresh Gopalan seeks review of a Patent Trial and Appeal Board (Board) decision affirming the examiner’s rejection of all pending claims of his U.S. Patent Application No. 13/926,096 (the ’096 Application) under 35 U.S.C. § 101. See Ex Parte Suresh Gopalan, No. 2018–003363, 2019 WL 2 IN RE: GOPALAN
764513 (P.T.A.B. Jan. 31, 2019). Because we agree with the Board that the claims are directed to an ineligible abstract idea, we affirm.
BACKGROUND In June 2013, Mr. Gopalan filed the ’096 Application, which is generally directed to methods and systems for designing measurement strategies. J.A. 58–127. The specification theorizes that the number of independent measures to be taken of a parameter of interest might be optimized for the number of true positives and false positives detected in the resulting data set. J.A. 64. In the context of measuring spectral signals, such as from fluorescent probes for detecting gene transcripts, the specification explains that these independent measurements can be made at different parts of an emission spectrum. J.A. 63.
The ’096 Application’s claims purport to provide a method for designing a measurement strategy that starts with a data set, applies an undefined optimization technique “resulting” in an optimal combination of true positives and false positives, and outputs the optimal number of measurements. Claim 1 is representative:
1. A computer implemented method for-devising spectrally based measurements, wherein a signal is measured at different point along a spectrum, the method comprising the steps of:
[1] selecting a number of measurements along the spectrum, constituting at least one data set; [2] selecting a metric for determining substantially optimal combination of true positives and false positives in said at least one data set; [3] applying an optimization technique; and
IN RE: GOPALAN 3
[4] obtaining, from the results of the optimization technique, a value for at least one optimization parameter, said value for at least one optimization parameter resulting in substantially optimal combination of true positives and false positives; wherein the obtaining at least one optimization parameter comprises obtaining a value of a number of independent measures; wherein obtaining a value of a number of independent measures comprises obtaining at least one combination of a value of a number of independent measures and a value for a confidence measure; said independent measures comprising measures of a parameter of spectral property being measured obtained using different measurement criteria ; [5] implementing a measurement strategy by placement of sensors or design of components that allow design of measurement by sensors to implement the number of independent measures; wherein the measurement strategy for the spectrally based measurements results from the number of independent measures; [6] wherein a number of true positives and false positives are a function of at least one combination of the number of independent measures and the confidence measure; and [7] wherein the steps of selecting a metric, applying an optimization technique, and obtaining, from the results of the optimization technique, a value are performed by means of a non-transitory computer usable medium having computer readable code
4 IN RE: GOPALAN
that causes a processor to perform the steps; [8] whereby such measurement are used in systems used in applications including nucleic acid sequencing, high spatial density measurement of spectrally based measurement , including fluorescence, based signals using scanners and cameras including for nucleic acid and protein measurements.
’096 Application at claim 1 (numbering added).
The preamble of claim 1 reveals that the claimed method is a design strategy for “spectrally based measurements .” The measurement strategy begins with [1] selecting a number of measurements along a spectrum that constitutes at least one data set. Then the claim recites [2] selecting a metric for the purpose and desired result of obtaining a substantially optimal combination of true positives and false positives in the data set. But the claims are not limited to any specific “metric,” nor do they specify any metric’s use to achieve the desired result.
The claim next recites [3] applying an optimization technique, which is [7] performed on a generic computer, and [4] obtaining the desired result of the optimization technique, i.e., a value for at least one optimization parameter “resulting in substantially optimal combination of true positives and false positives.” The claim states that obtaining this value for the optimization parameter includes obtaining a value of a number of independent measures, which, in turn, includes obtaining a combination of a value of independent measures and a value for a confidence measure. According to the claim, [6] “a number of true positives and false positives are a function of at least one combination of the number of independent measures and the confidence measure.” None of these variables—the metric, the optimization technique, the value for the optimization parameter, the value of the number of independent
IN RE: GOPALAN 5
measures, or the value for the confidence measure—are defined in the claims. The claims do not specify the use of these variables, but instead merely claim the desired result of optimizing the number of true positives and false positives .
The claim then recites [5] implementing the measurement strategy based on the value of the number of independent measures by placing sensors or design components. But neither the claims nor specification contain any concrete specificity regarding the placement or design of the sensors or components. The final limitation does not meaningfully limit the claim, as it recites [8] using the measurement strategy in applications optionally including nucleic acid sequencing and high spatial density measurement of spectrally based measurement.
The examiner rejected all pending claims under § 101 as being directed to the abstract ideas of collecting and organizing data and the mathematical concept of optimization . J.A. 601–03. Proceeding to step two of Alice, the examiner found that the claim elements do not provide any “inventive concept” that transforms the abstract idea into a patent-eligible application; rather, the claims require no more than the performance of generic functions that were well-understood, routine, and conventional. J.A. 603, 607– 08.
Mr. Gopalan appealed the examiner’s rejection to the Board. The Board affirmed the examiner’s § 101 rejection in an initial decision on appeal in January 2019 and a subsequent rehearing decision in May 2019. Gopalan, 2019 WL 764513, at *14; J.A. 26–33. Mr. Gopalan appeals the Board’s decision. We have jurisdiction pursuant to 28 U.S.C. § 1295(a)(4)(A).
DISCUSSION Patent eligibility under 35 U.S.C. § 101 is a question of law that may contain underlying issues of fact. Interval 6 IN RE: GOPALAN
Licensing LLC v. AOL, Inc., 896 F.3d 1335, 1342 (Fed. Cir. 2018) (citing Berkheimer v. HP Inc., 881 F.3d 1360, 1365 (Fed. Cir. 2018)). We review an ultimate conclusion on patent eligibility de novo. See id.
Free access — add to your briefcase to read the full text and ask questions with AI
In Re GOPALAN (In Re GOPALAN) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.